Stanssens P - Search Results

1

Engineering cysteine mutants to obtain crystallographic phases with a cutinase from Fusarium solani pisi.

Martinez C, de Geus P, Stanssens P, Lauwereys M, Cambillau C. Martinez C, et al. Among authors: stanssens p. Protein Eng. 1993 Feb;6(2):157-65. doi: 10.1093/protein/6.2.157. Protein Eng. 1993. PMID: 8475042

2

Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 2. Site-directed mutagenesis of the xylose binding site.

Lambeir AM, Lauwereys M, Stanssens P, Mrabet NT, Snauwaert J, van Tilbeurgh H, Matthyssens G, Lasters I, De Maeyer M, Wodak SJ, et al. Lambeir AM, et al. Among authors: stanssens p. Biochemistry. 1992 Jun 23;31(24):5459-66. doi: 10.1021/bi00139a006. Biochemistry. 1992. PMID: 1610792

3

An echistatin-like Arg-Gly-Asp (RGD)-containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function.

Deckmyn H, Stanssens P, Hoet B, Declerck PJ, Lauwereys M, Gansemans Y, Tornai I, Vermylen J. Deckmyn H, et al. Among authors: stanssens p. Br J Haematol. 1994 Jul;87(3):562-71. doi: 10.1111/j.1365-2141.1994.tb08313.x. Br J Haematol. 1994. PMID: 7993797

4

The integrin alpha 2 beta 1 (GPIa/IIa)-I-domain inhibits platelet-collagen interaction.

Depraetere H, Wille C, Gansemans Y, Stanssens P, Lauwereys M, Baruch D, De Reys S, Deckmyn H. Depraetere H, et al. Among authors: stanssens p. Thromb Haemost. 1997 May;77(5):981-5. Thromb Haemost. 1997. PMID: 9184414

5

Surface expression and ligand-based selection of cDNAs fused to filamentous phage gene VI.

Jespers LS, Messens JH, De Keyser A, Eeckhout D, Van den Brande I, Gansemans YG, Lauwereys MJ, Vlasuk GP, Stanssens PE. Jespers LS, et al. Among authors: stanssens pe. Biotechnology (N Y). 1995 Apr;13(4):378-82. doi: 10.1038/nbt0495-378. Biotechnology (N Y). 1995. PMID: 9634780

6

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs.

Ulrichts H, Silence K, Schoolmeester A, de Jaegere P, Rossenu S, Roodt J, Priem S, Lauwereys M, Casteels P, Van Bockstaele F, Verschueren K, Stanssens P, Baumeister J, Holz JB. Ulrichts H, et al. Among authors: stanssens p. Blood. 2011 Jul 21;118(3):757-65. doi: 10.1182/blood-2010-11-317859. Epub 2011 May 16. Blood. 2011. PMID: 21576702 Free article.

7

Arginine residues as stabilizing elements in proteins.

Mrabet NT, Van den Broeck A, Van den brande I, Stanssens P, Laroche Y, Lambeir AM, Matthijssens G, Jenkins J, Chiadmi M, van Tilbeurgh H, et al. Mrabet NT, et al. Among authors: stanssens p. Biochemistry. 1992 Mar 3;31(8):2239-53. doi: 10.1021/bi00123a005. Biochemistry. 1992. PMID: 1540579

8

Enhancing the thermostability of glucose isomerase by protein engineering.

Quax WJ, Mrabet NT, Luiten RG, Schuurhuizen PW, Stanssens P, Lasters I. Quax WJ, et al. Among authors: stanssens p. Biotechnology (N Y). 1991 Aug;9(8):738-42. doi: 10.1038/nbt0891-738. Biotechnology (N Y). 1991. PMID: 1367634

9

Subsite interactions of ribonuclease T1: viscosity effects indicate that the rate-limiting step of GpN transesterification depends on the nature of N.

Steyaert J, Wyns L, Stanssens P. Steyaert J, et al. Among authors: stanssens p. Biochemistry. 1991 Sep 3;30(35):8661-5. doi: 10.1021/bi00099a024. Biochemistry. 1991. PMID: 1909570

10

Histidine-40 of ribonuclease T1 acts as base catalyst when the true catalytic base, glutamic acid-58, is replaced by alanine.

Steyaert J, Hallenga K, Wyns L, Stanssens P. Steyaert J, et al. Among authors: stanssens p. Biochemistry. 1990 Sep 25;29(38):9064-72. doi: 10.1021/bi00490a025. Biochemistry. 1990. PMID: 1980211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters